RAPT Therapeutics Inc

NASDAQ:RAPT   3:59:54 PM EDT
13.68
+1.18 (+9.44%)
Earnings Announcements

RAPT Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/11/2022 12:12 GMT
RAPT Therapeutics Inc (RAPT) - Rapt Therapeutics Reports First Quarter 2022 Financial Results.
Qtrly Loss per Share $0.69.
Q1 Earnings per Share View $-0.68 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.23 Million
Adjusted EPS is expected to be -$0.73

Next Quarter Revenue Guidance is expected to be $0.18 Million
Next Quarter EPS Guidance is expected to be -$0.79

More details on our Analysts Page.